Radiation Therapy For Oropharyngeal Squamous Cell Carcinoma

Publication Date: August 1, 2017
Last Updated: March 14, 2022

Recommendations

When is it appropriate to add systemic therapy to definitive RT in the treatment of OPSCC?

In the scenario of stage IVA-B disease?

Concurrent high-dose intermittent cisplatin should be delivered to patients with stage IVA-B OPSCC receiving definitive RT. (Strong, High)
323259

Overview

Title

Radiation Therapy For Oropharyngeal Squamous Cell Carcinoma

Authoring Organization